Literature DB >> 17347658

Prognostic factors in squamous cell carcinoma of the penis.

Giacomo Novara1, Antonio Galfano, Vincenzo De Marco, Walter Artibani, Vincenzo Ficarra.   

Abstract

Squamous cell carcinoma (SCC) of the penis is an uncommon disease in the US and Europe. Without treatment, patients with penile SCC usually die within 2 years after diagnosis of the primary lesion, because of uncontrollable locoregional disease or from distant metastases. The spread of the tumor to the locoregional lymph nodes (lymph-node positivity) is the most relevant prognostic factor. With the available treatments, 5-year cancer-specific survival probabilities are between 75% and 93% for those patients with clinically node-negative disease, and progressively lower for those with increasingly extensive node-positive disease. Similarly, patients with pathologically proven negative nodes have 5-year cancer-specific survival probabilities ranging from 85% to 100%. While patients with a single positive superficial lymph node on pathology have very good cancer-related outcomes, patients with multiple involved lymph nodes have significantly less favorable outcomes. This article focuses on the most important issues that surround the prognosis of squamous cell carcinoma of the penis, with special attention to the prognostic nomograms for penile cancer patients published in 2006.

Entities:  

Mesh:

Year:  2007        PMID: 17347658     DOI: 10.1038/ncpuro0751

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  24 in total

1.  Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.

Authors:  Lance C Pagliaro; Dallas L Williams; Danai Daliani; Michael B Williams; William Osai; Michael Kincaid; Sijin Wen; Peter F Thall; Curtis A Pettaway
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

2.  Prevalence and Type Diversity of Human Papillomaviruses in Penile Cancers in Hungary.

Authors:  Miklós Damásdi; Ferenc Jakab; Krisztina Kovács; Miklós Oldal; Gábor Kemenesi; Eszter Szabó; István Vályi-Nagy; Ákos Pytel; László Farkas; Árpád Szántó
Journal:  Pathol Oncol Res       Date:  2015-12-10       Impact factor: 3.201

3.  Penile cancer: epidemiology and treatment.

Authors:  Gustavo Cardoso Guimarães; Rafael Malagoli Rocha; Stenio Cassio Zequi; Isabela Werneck Cunha; Fernando Augusto Soares
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

4.  A rare case of carcinoma cuniculatum of the penis in a 55-year-old.

Authors:  Paul Lau; Hector H Li Chang; Jose A Gomez; Petar Erdeljan; John R Srigley; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 5.  How accurate are present risk group assignment tools in penile cancer?

Authors:  Vincenzo Ficarra; G Novara; R Boscolo-Berto; W Artibani; M W Kattan
Journal:  World J Urol       Date:  2008-06-17       Impact factor: 4.226

6.  The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection.

Authors:  Jian-Ye Liu; Yong-Hong Li; Zhi-Ling Zhang; Kai Yao; Yun-Lin Ye; Dan Xie; Hui Han; Zhou-Wei Liu; Zi-Ke Qin; Fang-Jian Zhou
Journal:  World J Urol       Date:  2013-02-28       Impact factor: 4.226

Review 7.  The role of pathologic prognostic factors in squamous cell carcinoma of the penis.

Authors:  Antonio L Cubilla
Journal:  World J Urol       Date:  2008-09-03       Impact factor: 4.226

8.  Lymph node metastases and prognosis in penile cancer.

Authors:  Yao Zhu; Ding-Wei Ye
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

9.  The importance of microvessel density in predicting cancer progression in patients with penile squamous cell carcinoma.

Authors:  Aditi Arora; Ankur Bansal
Journal:  Int Urol Nephrol       Date:  2017-03-13       Impact factor: 2.370

10.  Impact of Examined Lymph Node Count and Lymph Node Density on Overall Survival of Penile Cancer.

Authors:  Pan Gao; Tianle Zhu; Jingjing Gao; Hu Li; Xi Liu; Xiansheng Zhang
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.